ImmuCell Corporation (ICCC) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.
Historical revenue and profitability trends for ImmuCell Corporation
The chart above illustrates ImmuCell Corporation's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of ImmuCell Corporation's business.
How efficiently ImmuCell Corporation converts revenue into profit
Profit margins reveal how much of each dollar of revenue ImmuCell Corporation retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project ImmuCell Corporation to continue focusing on sustainable operations. The consensus analyst rating is 5 based on 1 analyst.
Based on our comprehensive analysis, ImmuCell Corporation (ICCC) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of ImmuCell Corporation's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how ImmuCell Corporation stacks up against similar companies
Explore growth analysis for top stocks
Related: ICCC Valuation, ICCC Dividend, ICCC Financial Health
Compare: ICCC vs AAPL, ICCC vs MSFT, ICCC vs GOOGL